Showing results (301-310 of 367) with videos related to
Sort By:
Pageof 37
Cancer Science|July 9, 2024
Trastuzumab deruxtecan versus trastuzumab emtansine in Asian patients with HER2-positive metastatic breast cancerHiroji Iwata, Binghe Xu, Sung-Bae Kim, et al.Cancer Immunology, Immunotherapy : CII|August 6, 2024
Genomic and transcriptomic profiles associated with response to eribulin and nivolumab combination in HER-2-negative metastatic breast cancerChanghee Park, Koung Jin Suh, Se Hyun Kim, et al.Future Oncology (London, England)|September 16, 2024
A plain language summary of the CAPItello-291 study: Capivasertib in hormone receptor-positive advanced breast cancerNicholas C Turner, Mafalda Oliveira, Sacha J Howell, et al.Journal for Immunotherapy of Cancer|October 20, 2020
Clinical advantage of targeted sequencing for unbiased tumor mutational burden estimation in samples with low tumor purityTae Hee Hong, Hongui Cha, Joon Ho Shim, et al.The Lancet. Oncology|August 31, 2020
Veliparib with carboplatin and paclitaxel in BRCA-mutated advanced breast cancer (BROCADE3): a randomised, double-blind, placebo-controlled, phase 3 trialVéronique Diéras, Hyo S Han, Bella Kaufman, et al.Annals of Hematology|July 19, 2006
Nodal marginal zone B-cell lymphoma: Analysis of 36 cases. Clinical presentation and treatment outcomes of nodal marginal zone B-cell lymphomaSung Yong Oh, Baek-Yeol Ryoo, Won Seog Kim, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2026
Exploratory analysis of PTEN deficiency by immunohistochemistry from the Phase III CAPItello-291 trialKomal Jhaveri, Hope S Rugo, Javier Cortés, et al.European Journal of Cancer (Oxford, England : 1990)|June 21, 2005
Extranodal nasal type NK/T-cell lymphoma: elucidating clinical prognostic factors for risk-based stratification of therapyJeeyun Lee, Yeon Hee Park, Won Seog Kim, et al.Annals of Surgical Oncology|February 6, 2015
The Value of Ki67 in Very Young Women with Hormone Receptor-Positive Breast Cancer: Retrospective Analysis of 9,321 Korean WomenJisun Kim, Wonshik Han, So-Youn Jung, et al.The New England Journal of Medicine|December 12, 2019
Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast CancerShanu Modi, Cristina Saura, Toshinari Yamashita, et al.Pageof 37